Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-06

Clinical Trial Update: Imaging a Cholinergic Biomarker of Cognition in Parkinson's Disease

View source ↗

Summary

The clinical trial investigating imaging a cholinergic biomarker of cognition in Parkinson's disease sponsored by Stony Brook University has been terminated, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stony Brook University | Conditions: Parkinson's Disease | Status: TERMINATED